A Coronary IVUS Study to Compare Torcetrapib/Atorvastatin to Atorvastatin Alone in Subjects With Coronary Heart Disease

Inclusion Criteria:

• angiographic evidence of coronary atherosclerosis

Exclusion Criteria:

• Women who are pregnant or lactating, or planning to become pregnant.

• Subjects with a clinically indicated need for statin (HMG-CoA reductase inhibitor)therapy other than atorvastatin or other concomitant therapy with known lipid alteringeffects on LDL-C and HDL-C including fibrates and nicotinic acid.

• Subjects taking any drugs known to be associated with an increased risk of myositis incombination with HMG-CoA reductase inhibitors.

• Subjects with any other medical condition or laboratory abnormality which could affectsubject safety, preclude evaluation of response, or render unlikely that the subjectwould complete the study.